University of Chicago SARS-CoV-2 Serosurvey Pilot Study
How to cite
Greenstone, Michael; Hortacsu, Ali; Mogstad, Magne; Torgovitsky, Alexander; Dijk, Winnie van; Shaikh, Azeem. 2022. "University of Chicago SARS-CoV-2 Serosurvey Pilot Study." AEA RCT Registry. AEARCTR-0010630. https://doi.org/10.1257/rct.10630-1.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
The purpose of this pilot study is to measure participation rates--at different levels of compensation and by neighborhood (zip) characteristics--in a serosurvey aimed at measuring the population prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) antibodies in Chicago.
Intervention
Sampled households were sent a package that contained a self-administered blood collection kit. The package additionally contained a consent form with a short questionnaire, instructions on self-administering and returning a blood sample, a letter explaining the purpose of the study and providing information on financial compensation for participating (i.e., returning a blood sample), and a pre-paid return package. Households in the sample were randomly assigned one of three levels of compensation: $0, $100, or $500.
While the study involves random assignment to varied incentive groups, it is not experimentally testing the efficacy or effectiveness or any product, device, or laboratory test. The only intervention is the random offer of incentive, the at-home blood collection kit, and the short questionnaire.
Experimental design
NORC constructed a sampling frame using United States Postal Service Data from the city of Chicago. They then randomly sampled 882 addresses from this sampling frame. Sampled households were sent a package that contained a self-administered blood collection kit, and were asked to return a blood sample of the adult in the household with the earliest upcoming birthday to the Wilson Antibody Biology Laboratory to be tested for seropositivity. The package additionally contained a consent form with a short questionnaire, instructions on self-administering and returning a blood sample, a letter explaining the purpose of the study and providing information on financial compensation for participating (i.e., returning a blood sample), and a pre-paid return package. Households in the sample were randomly assigned one of three levels of compensation: $0, $100, or $500. Reminder postcards were sent to households who had not yet returned a testing kit.
Design details
Cited by
No citation data available for this registration yet.